Adult vaccination, questions around immune-senescence (loss of immunity over time), and new vaccines licensed for adults and older people are becoming central topics of interest, with the potential for public health and economic gains.
Cijepljenje odraslih, pitanje gubitka imuniteta tijekom vremena i nova cjepiva licencirana za odrasle i starije osobe postaju središnje teme interesa zbog potencijalnih dobitaka u javnozdravstvenom i gospodarskom smislu.